Association of EWS-FLI1 Type 1 Fusion with Lower Proliferative Rate in Ewing's Sarcoma
- 1 March 2000
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 156 (3), 849-855
- https://doi.org/10.1016/s0002-9440(10)64953-x
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society (96/2102, 99–216)
This publication has 48 references indexed in Scilit:
- EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destructionOncogene, 1998
- Proliferative activity (MIB‐1 index) is an independent prognostic parameter in patients with high‐grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomasHistopathology, 1998
- Progress in the Molecular Biology of Ewing TumorsSarcoma, 1998
- EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenicNature Genetics, 1997
- Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemiasOncogene, 1997
- Role of the IGF-I receptor in mutagenesis and tumor promotionJournal of Endocrinology, 1997
- p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon eventMolecular Pathology, 1995
- Prognostic value of Ki‐67 expression in 182 soft tissue sarcomas. Proliferation — a marker of metastasis?APMIS, 1994
- p53 mutations in human tumors with chimeric EWS/FLI/1 genesInternational Journal of Cancer, 1994
- Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.JCI Insight, 1990